Market capitalization | $16.13m |
Enterprise Value | $17.00m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
P/B ratio (TTM) P/B ratio | negative |
Revenue (TTM) Revenue | $0.00 |
EBIT (operating result TTM) EBIT | $-1.67m |
Free Cash Flow (TTM) Free Cash Flow | $-1.59m |
Cash position | $40.00k |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Sep '24 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | -0.01 -0.01 |
-
|
|
EBITDA | -1.66 -1.66 |
34%
34%
|
EBIT (Operating Income) EBIT | -1.67 -1.67 |
34%
34%
|
Net Profit | -1.66 -1.66 |
41%
41%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It also offers HemoStyp to control bleeding. The company was founded on February 28, 1997 and is headquartered in Mount Laurel, NJ.
Head office | United States |
CEO | Brian Thom |
Employees | 10 |
Founded | 1997 |
Website | www.uhpcorp.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.